NMR Stock Chart & Stats
€371.70
-€12.60(-3.28%)
At close: 4:00 PM EDT
€371.70
-€12.60(-3.28%)
Day’s Range― - ―
52-Week Range€203.80 - €527.80
Previous CloseN/A
Volume0.00
Average Volume (3M)43.00
Market Cap
€10.27B
Enterprise Value€18.49K
Total Cash (Recent Filing)€1.02B
Total Debt (Recent Filing)€803.50M
Price to Earnings (P/E)41.3
Beta0.51
Next Earnings
Nov 05, 2026EPS Estimate
2.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.68
Shares Outstanding31,782,972
10 Day Avg. Volume30
30 Day Avg. Volume43
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)7.50
Price to Sales (P/S)11.23
P/FCF Ratio45.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€463.21Price Target Upside24.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)9.23
Revenue Forecast (FY)€931.42M
Bulls Say, Bears Say
Bulls Say
High Margins And ProfitabilitySustained high gross and net margins provide durable earnings power in capital-equipment markets. Strong margin structure supports reinvestment in R&D, capacity and shareholder returns, and offers cushion through semiconductor downcycles, underpinning long-term competitive reinvestment.
Market-share Gains And Product WinsMeaningful market-share gains signal improving competitive position and customer validation. Tool‑of‑record decisions and share gains boost scale, increase customer lock‑in and aftermarket opportunities, and raise barriers for rivals—advantages that persist across multiple fabs and node transitions.
Growing Recurring/service RevenueConsistent sequential growth in service revenue diversifies income away from lumpy tool sales. A larger installed base and stronger service take‑rates increase revenue visibility, margin stability and lifetime customer economics, helping smooth cyclicality inherent in capital spending.
Bears Say
Elevated Leverage Versus 2024The step‑up in absolute debt and higher debt-to-equity reduces financial flexibility during cyclical troughs. Elevated leverage can constrain capital allocation for R&D or capex, increase funding cost sensitivity, and limit ability to absorb demand shocks in a volatile semiconductor cycle.
Cash-flow Consistency RiskWhile cash conversion is strong in absolute terms, recent negative TTM free‑cash‑flow growth and OCF volatility indicate timing and working‑capital swings. That inconsistency can complicate predictable funding for expansion, debt paydown and dividends during lower demand periods.
Competitive And Demand‑visibility RisksIntensifying local competition in China and in material/XPS metrology, plus uncertain process‑control spending intensity, threaten pricing and share in key segments. These structural market dynamics could weaken long‑run growth and margins if competitors scale or customers shift sourcing.
Nova News
NMR FAQ
What was Nova’s price range in the past 12 months?
Nova lowest stock price was €203.80 and its highest was €527.80 in the past 12 months.
What is Nova’s market cap?
Nova’s market cap is €10.27B.
When is Nova’s upcoming earnings report date?
Nova’s upcoming earnings report date is Nov 05, 2026 which is in 72 days.
How were Nova’s earnings last quarter?
Nova released its earnings results on Aug 06, 2026. The company reported €2.172 earnings per share for the quarter, beating the consensus estimate of €2.087 by €0.085.
Is Nova overvalued?
According to Wall Street analysts Nova’s price is currently Undervalued.
Does Nova pay dividends?
Nova does not currently pay dividends.
What is Nova’s EPS estimate?
Nova’s EPS estimate is 2.4.
How many shares outstanding does Nova have?
Nova has 31,782,972 shares outstanding.
What happened to Nova’s price movement after its last earnings report?
Nova reported an EPS of €2.172 in its last earnings report, beating expectations of €2.087. Following the earnings report the stock price went down -4.983%.
Which hedge fund is a major shareholder of Nova?
Currently, no hedge funds are holding shares in DE:NMR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nova Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€463.21 (24.62% Upside)
€463.21 (24.62% Upside)
Blogger Sentiment
Bullish
DE:NMR Sentiment 88%
Sector Average 59%
Sector Average 59%
Insider Transactions
Sold Shares
Worth €3.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
62.32%
Trailing 12-Months
Company Description
Nova
Nova Ltd. is a global innovator specializing in the design, development, production, and sale of sophisticated process control systems vital for semiconductor manufacturing. Its extensive reach covers key regions such as Israel, Taiwan, the United States, China, and Korea, in addition to other international markets. The company's advanced product range includes a suite of metrology platforms, enabling precise measurements of dimensions, films, materials, and chemical compositions. These capabilities are crucial for ensuring meticulous process control throughout various stages of semiconductor fabrication, including lithography, etching, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. Nova serves diverse segments of the integrated circuit manufacturing industry, providing solutions to leading logic, foundry, and memory producers, as well as manufacturers of process equipment. Headquartered in Rehovot, Israel, and established in 1993, the company changed its name to Nova Ltd. in July 2021, having previously been known as Nova Measuring Instruments Ltd.
NMR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: record revenue, record profitability, market-share gains (400 bps), broad-based product and service strength, and upward guidance for Q2. Management addressed risks but presented clear mitigation steps (capacity expansion, supplier management, R&D investment). The lowlights—supplier cost pressure, competition (notably in China and XPS/material metrology), a slightly elevated tax rate, and some uncertainty on process-control dynamics—are notable but relatively limited compared with the positive financial outcomes and strategic progress.View all DE:NMR earnings summariesNMR Stock 12 Month Forecast
Average Price Target
€463.21
▲(24.62% Upside)